PCOS Weight Loss With Hypothyroidism: What Treating It Actually Changes

How Often Do PCOS and an Underactive Thyroid Actually Overlap?

About one in five women with PCOS — 19.7% in a 2025 meta-analysis of 29 studies and 5,765 women — has subclinical hypothyroidism, a mildly raised TSH with a still-normal free T4 (Shekarian et al. 2025). This page sits inside the wider PCOS weight-loss coverage on this site, and it narrows in on one question that general coverage does not answer: once both diagnoses are confirmed, what does treating the thyroid actually do to weight, and does leaving it undertreated make the PCOS side of the picture worse? The diet and medication-timing side of both conditions is already covered elsewhere in full, and telling the two conditions apart with a blood panel is the step that has to happen first — this page assumes that work is already done.

You may see this condition written as polyendocrine metabolic ovarian syndrome (PMOS), the name a 2026 global consensus of more than 50 organisations gave the same condition. Nothing below changes under either name; this article uses PCOS because that is still what most readers search.

How Does an Underactive Thyroid Make PCOS’s Insulin Resistance Worse?

Women with PCOS and subclinical hypothyroidism carry HOMA-IR values 0.78 points higher, and higher fasting insulin, than women with PCOS and a normal thyroid, in the same 2025 meta-analysis of 29 studies (Shekarian et al. 2025). That gap has a mechanism behind it, not just a correlation: thyroid hormone has insulin-antagonistic effects at the liver, pushing it to manufacture more glucose through gluconeogenesis, while also blunting how well peripheral tissue takes up glucose in response to insulin — the same broad pattern seen in PCOS itself, arriving through a second, independent pathway (Brenta 2011). Insulin resistance and PCOS covers PCOS’s own baseline insulin-sensitivity deficit in full; an underactive thyroid does not replace that mechanism, it stacks a second one on top of it.

How Much Weight Does Treating Overt Hypothyroidism Actually Change?

Treating overt hypothyroidism cut average body weight from 83.7 kg to 79.4 kg — a 4.3 kg drop — over one year in a controlled trial of 12 women newly diagnosed with the condition, and DEXA scans showed none of it came from fat (Karmisholt et al. 2011). TSH fell from an average of 102 to 2.2 mU/L in that year, which is a severe, overt case resolving into a treated one, not a borderline result. The weight that came off tracked with lean mass only; fat mass and bone mass were virtually unchanged, while resting energy expenditure rose. The researchers’ own conclusion was that this is fluid — excess body water that had built up as myxoedema — leaving the body’s underlying fat store untouched by the treatment itself.

A 2016 review of the wider evidence describes the same shape in broader strokes: overt hypothyroidism carries a real but modest weight gain, and treating it produces “at most a modest” weight loss in return — the same word used deliberately in both directions (Sanyal & Raychaudhuri 2016).

Does Treating Subclinical Hypothyroidism Do Anything for Weight?

Levothyroxine produced no significant change in BMI in a 2022 meta-analysis pooling 13 trials of subclinical hypothyroidism treatment in adults aged 60 and older (Zhao et al. 2022). The same review found real benefit elsewhere — treatment significantly lowered total cholesterol, triglycerides, LDL cholesterol and apolipoprotein B — but weight, fatigue, general symptoms, quality of life and cognitive function all showed no significant change. That trial population is older adults rather than reproductive-age women with PCOS, so this is the best available evidence rather than a PCOS-specific number, and it is worth naming plainly: it maps onto exactly the subclinical group behind the 19.7% figure above.

Why Do Two People With PCOS Have Different TSH Treatment Targets?

Two labs can print two different reference ranges for an identical TSH result, because each range is built from that lab’s own assay and its own reference population. That is a reason this article will not tell you what your own TSH number means, whether it counts as “controlled,” or whether your current dose is right. Interpreting your specific thyroid panel is work for whoever manages that prescription, against your own lab’s range and full clinical picture — not a number in an article. What a treatment target should be for you specifically depends on your symptoms, your weight trend, and whether pregnancy is part of your near-term plans, and it is set collaboratively with your prescriber rather than derived from a general rule.

Do Levothyroxine and Your PCOS Supplements Interact?

Five ordinary things reduce how much levothyroxine actually reaches your bloodstream: calcium, iron, magnesium, coffee, and high dietary fibre (Liwanpo & Hershman 2009). That list matters more here than it would on most pages, because PCOS weight-loss advice routinely pushes toward several of those at once — a higher-fibre eating pattern, a magnesium supplement for its plausible insulin-resistance benefit, or a calcium- or iron-containing multivitamin. Magnesium is the newest addition to the interaction list: a 2025 randomized crossover trial in 15 healthy adults found magnesium aspartate reduced levothyroxine absorption by a significant 12% (95% CI 4–19%), while magnesium citrate reduced it by a smaller, non-significant 7% (ThyroMag trial, 2025).

None of this means changing your levothyroxine dose or its schedule on your own initiative. It means the timing of a fibre-heavy breakfast, a magnesium supplement, or your morning coffee relative to that dose is a specific, useful question for whoever prescribes it — particularly if your TSH has drifted despite a stable dose and a genuinely improved diet, since timing is a more likely explanation than the diet change itself working against you.

This Will Not Fix a PCOS Weight Plateau If…

Two groups reading this page are chasing a lever that will not move for them, and naming them is more useful than another kilogram figure. If your TSH and free T4 are already stable on treatment, none of the trial evidence above found further weight benefit from adjusting an already-adequate dose — PCOS’s own insulin resistance, present regardless of thyroid status, is the more likely remaining explanation, and it has its own separate evidence base for what actually moves it. If your hypothyroidism is subclinical rather than overt, the current trial evidence gives no basis to expect any weight change at all from starting or adjusting treatment, whatever else it may improve.

Neither of the two trials above enrolled a specifically PCOS population, ran longer than a year, or followed anyone through pregnancy — thyroid hormone needs shift meaningfully once pregnancy begins, and that recalibration belongs to whoever manages your prenatal and thyroid care together, not to this page. And if what you pictured was a visible transformation, the strongest trial available says plainly that the number on the scale after treatment is mostly water leaving, not fat — a real result, just not the one “treating my thyroid will fix my weight” usually implies.

Your Next Step

Bring two specific questions to your next appointment rather than a general complaint about the scale. First: “Is my hypothyroidism overt or subclinical, and has that changed since I was diagnosed?” — the distinction above is the difference between a real, if modest, expected weight shift and none at all. Second, if you take a fibre-heavy diet, magnesium, calcium or iron seriously as part of your PCOS routine: “Is the timing of that relative to my levothyroxine dose worth adjusting?” The fuller PCOS weight-loss picture — diet composition, exercise, metformin and GLP-1 trial data — is the next stop once your thyroid status is accounted for and the remaining lever is PCOS itself.